Security Snapshot

DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO) Institutional Ownership

CUSIP: 23725P209

13F Institutional Holders and Ownership History from Q4 2019 to Q4 2025

Latest Period

Q4 2025

Institutions Reporting

0

Shares (Excl. Options)

0

Price

$0.55

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
DRIO on Nasdaq
Shares outstanding
6,768,178
Price per share
$0.55
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
0
Total reported value
$0
Share change
-97,271
Value change
-$1,548,468
Number of holders
0
Price from insider filings
$0.55
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • DRIO - DarioHealth Corp. - Common Stock, par value $0.0001 per share is tracked under CUSIP 23725P209.
  • 0 institutions reported positions in Q4 2025.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 4 to 0 between Q3 2025 and Q4 2025.
  • Reported value moved from $1,951,788 to $0.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 0 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 23725P209?
CUSIP 23725P209 identifies DRIO - DarioHealth Corp. - Common Stock, par value $0.0001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 10% 0% $3,376,814 +$847,493 4,690,019 +34% Nantahala Capital Management, LLC 30 Jun 2025
Nantahala Capital Partners Limited Partnership 5.8% $2,059,118 2,511,120 NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 27 Feb 2025
Solid Financial LLC 5.6% +20% $1,754,506 +$300,131 2,139,642 +21% Solid Financial LLC 12 Feb 2025
Tasso Partners, LLC 10% +26% $11,730,979 -$49,324,065 676,141 -81% Tasso Partners, LLC 30 Sep 2025

As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO). This represents 0% of the company’s total 6,768,178 outstanding shares.

Institutional Holders of DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$1,548,468 $0.55 0
2025 Q3 120,517 $1,951,788 -$40,206,854 $17.35 4
2025 Q2 7,053,140 $4,725,771 -$194,687 $0.67 37
2025 Q1 7,373,383 $4,513,334 -$258,791 $0.61 40
2024 Q4 7,764,566 $6,103,693 -$430,067 $0.79 37
2024 Q3 8,022,288 $8,977,559 -$213,280 $1.12 31
2024 Q2 8,191,011 $9,750,038 -$1,020,609 $1.19 38
2024 Q1 8,958,378 $13,713,509 +$446,557 $1.53 34
2023 Q4 8,661,570 $15,154,371 -$5,112,000 $1.72 36
2023 Q3 10,068,027 $33,022,476 +$3,242,090 $3.28 41
2023 Q2 9,072,865 $36,382,530 -$782,420 $4.01 45
2023 Q1 9,258,568 $38,144,699 -$319,817 $4.12 44
2022 Q4 9,332,828 $39,186,189 -$2,275,720 $4.28 46
2022 Q3 8,331,573 $38,368,000 -$7,465,063 $4.63 40
2022 Q2 9,445,542 $57,996,000 -$8,563,326 $6.14 52
2022 Q1 11,001,191 $63,710,000 +$18,381,439 $5.84 61
2021 Q4 7,751,021 $100,546,000 +$6,975,699 $12.97 57
2021 Q3 7,189,120 $98,181,000 -$15,363,553 $13.65 55
2021 Q2 7,564,790 $161,700,000 +$47,351,810 $21.36 57
2021 Q1 5,466,339 $105,116,648 +$61,166,102 $19.26 54
2020 Q4 2,377,092 $33,959,945 +$7,877,859 $14.29 25
2020 Q3 1,822,496 $29,132,627 +$22,411,309 $16.78 24
2020 Q2 411,122 $2,609,970 +$756,512 $6.34 14
2020 Q1 291,928 $1,982,437 +$67,437 $6.79 10
2019 Q4 282,178 $1,850,000 +$1,847,000 $6.55 9
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .